Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Vertex Pharmaceuticals Inc., consolidated balance sheet: assets (quarterly data)

US$ in thousands

	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash and cash equivalents	5,492,900)	5,084,800)	4,939,600)	4,972,200)	4,674,700)	4,569,600)	5,239,200)	4,580,100)	9,158,000)	10,369,100)	11,110,200)	10,151,100)	9,289,900)	10,504,000)	9,171,500)	8,702,200)	7,600,100)	6,795,000)	6,275,698)	6,063,678)	6,304,330)
Marketable securities	1,753,800)	1,523,300)	1,347,400)	1,410,600)	1,526,500)	1,546,300)	1,285,300)	1,215,400)	1,013,300)	849,200)	818,000)	1,085,200)	1,124,200)	274,500)	599,200)	551,200)	638,000)	729,900)	685,187)	644,315)	619,638)
Accounts receivable, net	1,996,100)	2,052,800)	1,946,400)	1,893,500)	1,805,100)	1,609,400)	1,750,600)	1,656,100)	1,793,200)	1,563,400)	1,538,700)	1,556,200)	1,547,800)	1,442,200)	1,385,200)	1,332,900)	1,292,800)	1,136,800)	1,100,372)	929,142)	977,551)
Inventories	1,766,700)	1,686,800)	1,626,800)	1,499,300)	1,359,700)	1,205,400)	1,079,800)	914,600)	813,100)	738,800)	688,700)	603,500)	535,100)	460,600)	388,200)	367,700)	338,900)	353,100)	333,456)	321,620)	298,863)
Prepaid expenses and other current assets	720,800)	853,300)	709,400)	652,300)	642,800)	665,700)	449,200)	575,400)	511,100)	623,700)	540,200)	476,900)	468,700)	553,500)	726,900)	549,500)	491,500)	545,800)	457,827)	498,759)	338,925)
Current assets	11,730,300)	11,201,000)	10,569,600)	10,427,900)	10,008,800)	9,596,400)	9,804,100)	8,941,600)	13,288,700)	14,144,200)	14,695,800)	13,872,900)	12,965,700)	13,234,800)	12,271,000)	11,503,500)	10,361,300)	9,560,600)	8,852,540)	8,457,514)	8,539,307)
Property and equipment, net	1,608,400)	1,520,300)	1,425,100)	1,335,100)	1,295,900)	1,227,800)	1,117,800)	1,200,900)	1,172,800)	1,159,300)	1,124,000)	1,122,400)	1,111,700)	1,108,400)	1,118,700)	1,100,100)	1,107,400)	1,094,100)	1,042,347)	1,021,233)	986,123)
Goodwill	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,075,200)	1,002,200)	1,002,200)	1,002,200)	1,002,158)	1,002,158)	1,002,158)
Other intangible assets, net	418,500)	424,200)	429,800)	435,500)	441,200)	825,900)	831,600)	837,500)	834,900)	839,900)	603,600)	603,600)	603,600)	603,600)	603,600)	387,000)	400,000)	400,000)	400,000)	400,000)	400,000)
Deferred tax assets	2,947,800)	2,897,900)	2,937,200)	2,711,700)	2,544,300)	2,331,100)	2,308,900)	2,185,600)	1,963,000)	1,812,100)	1,729,100)	1,538,000)	1,359,900)	1,246,900)	1,162,700)	1,143,800)	945,500)	934,500)	933,839)	952,808)	815,890)
Operating lease assets	1,685,100)	1,562,700)	1,591,800)	1,313,800)	1,338,500)	1,356,800)	1,396,100)	569,800)	312,900)	293,600)	310,500)	324,300)	336,300)	347,400)	342,700)	318,300)	329,000)	330,300)	312,343)	316,874)	322,319)
Long-term marketable securities	5,749,900)	5,712,300)	5,722,800)	5,645,900)	5,156,500)	5,107,900)	4,703,500)	4,393,100)	4,381,400)	2,497,800)	1,700,000)	1,357,300)	1,081,500)	112,200)	—)	—)	—)	—)	—)	—)	—)
Other assets	1,256,400)	1,236,600)	1,098,000)	1,078,800)	1,007,300)	999,300)	990,200)	915,600)	875,700)	895,300)	475,200)	442,700)	427,500)	409,600)	132,500)	127,300)	110,700)	110,800)	75,518)	71,099)	49,262)
Long-term assets	14,754,100)	14,442,000)	14,292,700)	13,608,800)	12,871,700)	12,936,800)	12,436,100)	11,190,500)	10,628,700)	8,586,000)	7,030,400)	6,476,300)	6,008,500)	4,916,100)	4,435,400)	4,078,700)	3,894,800)	3,871,900)	3,766,205)	3,764,172)	3,575,752)
Total assets	26,484,400)	25,643,000)	24,862,300)	24,036,700)	22,880,500)	22,533,200)	22,240,200)	20,132,100)	23,917,400)	22,730,200)	21,726,200)	20,349,200)	18,974,200)	18,150,900)	16,706,400)	15,582,200)	14,256,100)	13,432,500)	12,618,745)	12,221,686)	12,115,059)

Total assets exhibit a substantial long-term growth trajectory, increasing from 12.1 billion US dollars in March 2021 to approximately 26.5 billion US dollars by March 2026. While the overall trend is upward, a notable contraction occurred in the first half of 2024, where total assets declined from 23.9 billion US dollars in December 2023 to 20.1 billion US dollars in March 2024, before resuming a steady climb.

Liquidity and Cash Management: A significant shift in the composition of liquid assets is observed. Cash and cash equivalents grew steadily from 6.3 billion US dollars in early 2021 to a peak of 11.1 billion US dollars in September 2023. However, a sharp reduction occurred between December 2023 and June 2024, with balances falling from 10.4 billion US dollars to 4.6 billion US dollars. This reduction in immediate liquidity is partially offset by a strategic reallocation into long-term marketable securities, which were virtually non-existent in early 2021 but grew to 5.7 billion US dollars by March 2026.
Operational Asset Growth: Working capital components show consistent expansion, reflecting scaled operations. Accounts receivable, net, nearly doubled over the period, rising from 977.6 million US dollars in March 2021 to approximately 2 billion US dollars by March 2026. Even more pronounced is the growth in inventories, which increased from 298.9 million US dollars to 1.77 billion US dollars, suggesting a significant increase in production capacity or the introduction of new product lines.
Long-Term Infrastructure and Investment: Long-term assets expanded from 3.6 billion US dollars in March 2021 to 14.8 billion US dollars in March 2026. This growth was primarily driven by the aforementioned long-term marketable securities and a surge in operating lease assets, which jumped from 312.9 million US dollars in March 2024 to 1.69 billion US dollars by March 2026, indicating expanded facility footprints. Property and equipment, net, also showed a gradual increase from 986.1 million US dollars to 1.6 billion US dollars.
Tax and Intangible Assets: Deferred tax assets demonstrate a consistent and strong upward trend, increasing from 815.9 million US dollars in March 2021 to 2.95 billion US dollars in March 2026. In contrast, goodwill remained relatively stable, hovering around 1.09 billion US dollars for the majority of the period, suggesting that asset growth has been driven by organic expansion and financial investments rather than significant acquisitions.

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

Balance Sheet: Assets
Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data